Case Studies

Foresight Language and Learning Solution Limited

Foresight Language and Learning Solutions Limited develops evidence-based technological solutions to enhance diagnosis and treatment of language and learning disorders and delivers evidence-based solutions to individuals with language and learning disorders in order to improve their quality of life.

Learn More

Foresight Language and Learning Solution Limited

Foresight Language and Learning Solutions Limited develops evidence-based technological solutions to enhance diagnosis and treatment of language and learning disorders and delivers evidence-based solutions to individuals with language and learning disorders in order to improve their quality of life.

未來機器人(深圳)有限公司 VisionNav Robotics

未來機器人(深圳)有限公司由東京大學,香港中文大學博士團隊創立於2016年,總部位於深圳,在香港,佛山設有分公司。現爲國家高新技術企業,並得到香港創新科技署ESS、深圳市科創委等重點項目資助。目前,公司已獲得CE、ISO等專業體系咨詢認證,擁有超過50項行業獨有的關鍵科技專利。

Learn More

未來機器人(深圳)有限公司 VisionNav Robotics

未來機器人(深圳)有限公司由東京大學,香港中文大學博士團隊創立於2016年,總部位於深圳,在香港,佛山設有分公司。現爲國家高新技術企業,並得到香港創新科技署ESS、深圳市科創委等重點項目資助。目前,公司已獲得CE、ISO等專業體系咨詢認證,擁有超過50項行業獨有的關鍵科技專利。

SmartEye Tech Limited

Smarteye Tech Limited, a provider of high speed and high resolution 3D vision products and solutions, is founder by members from first-class universities such as the Chinese University of Hong Kong, the Chinese Academy of Sciences and Shanghai Jiaotong University. The president, Dr. Liu Yunhiu, an IEEE fellow and an HKIE academician in Hong Kong, is currently a professor at the Chinese University of Hong Kong. Professor Liu is a world-class expert in machine vision and robotics. The core R&D team is headed by CEO Dr. Lv Congyi.

Learn More

SmartEye Tech Limited

Smarteye Tech Limited, a provider of high speed and high resolution 3D vision products and solutions, is founder by members from first-class universities such as the Chinese University of Hong Kong, the Chinese Academy of Sciences and Shanghai Jiaotong University. The president, Dr. Liu Yunhiu, an IEEE fellow and an HKIE academician in Hong Kong, is currently a professor at the Chinese University of Hong Kong. Professor Liu is a world-class expert in machine vision and robotics. The core R&D team is headed by CEO Dr. Lv Congyi.

CodeX Genetics Limited

Founded in 2013 and with the prime focus on managing genetic diseases, Codex aims to provide holistic, clinically-actionable disease management solutions to patients suffering from neurological disorders or cancers, through AI-powered analytics on both genetic and clinical data. With our proven track-record in market, Codex is confident in realizing and marketing the latest personalized disease management solution to the public, specifically in Hong Kong and China.

Learn More

CodeX Genetics Limited

Founded in 2013 and with the prime focus on managing genetic diseases, Codex aims to provide holistic, clinically-actionable disease management solutions to patients suffering from neurological disorders or cancers, through AI-powered analytics on both genetic and clinical data. With our proven track-record in market, Codex is confident in realizing and marketing the latest personalized disease management solution to the public, specifically in Hong Kong and China.

Imsight Medical Technology Co. Ltd

Shenzhen Imsight Medical Technology Co. Ltd. is a company of scientific and technological innovation specialized in AI-based medical imaging. The company has developed a series of fast and accurate intelligent medical imaging products based on AI deep learning and the computerized medical imaging analysis technology. Based on AI deep learning and intelligent analysis on the big data derived from medical imaging, the series of products provide effective auxiliary solutions for clinical application to improve the accuracy and efficiency of clinical diagnosis and treatment.

Learn More

Imsight Medical Technology Co. Ltd

Shenzhen Imsight Medical Technology Co. Ltd. is a company of scientific and technological innovation specialized in AI-based medical imaging. The company has developed a series of fast and accurate intelligent medical imaging products based on AI deep learning and the computerized medical imaging analysis technology. Based on AI deep learning and intelligent analysis on the big data derived from medical imaging, the series of products provide effective auxiliary solutions for clinical application to improve the accuracy and efficiency of clinical diagnosis and treatment.

Imsight has set up multiple R&D centers in Shenzhen, Hong Kong, Beijing, Chengdu, Guiyang, etc., forming a market strategy layout dominated by North China, Central China, South China, Southwest China, etc. By June 2018, Imsight had obtained over 100 million of financial support from Shenzhen Capital Group Co., Ltd, Lenovo Capital, China Merchants Innovation Investment Management Co., Ltd., etc. At present, the company has established a long-term and stable scientific research partnership with over a hundred of famous hospitals at home and abroad.

Mr. Chen Hao (Founder & CEO)

  • Chen Hao is the doctor of computer science of Chinese University of Hong Kong, and had ever been granted by Hong Kong Fellowship Scheme. As a leader, his team had ever defeated the teams from Google and MIT and won the champions for several times in dozens of international challenges in medical images analysis and identification. He had published dozens of papers on top conferences and journals, including a paper on 3D FCN which won the Best Paper Award in 2016 Miar and 2017MIA-MICCAI.

Mr. Pheng-Ann Heng (Co-Founder & Chief Scientist)

  • Pheng-Ann Heng is a Yangtze River Scholar appointed by the Ministry of Education professor of the Department of Computer Science and Engineering, and the director of Key Strategies Research in Computer-Aided Medical Field of CUHK, and the director of Human-Computer Interaction Center at Shenzhen Institute of Advanced Integration Technology, Chinese Academy of Science. He had published over 500 academic papers, including over 200 papers on the international leading journals, with Google citations up to 9000+.

Website

https://www.imsighmed.com/

Media Coverage

https://www.imsightmed.com/enews/index/id/23.html

Milestone